Covington-Led Immunotherapy Co. IFM Lands $56M Financing
By McCord Pagan ( December 2, 2019, 2:20 PM EST) -- Covington & Burling-backed drug researcher IFM Therapeutics said Monday it has closed on a $55.5 million financing round to fund two new subsidiaries and further immunotherapy research for certain inflammatory diseases and cancers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.